Interventional Study on the Evaluation of Functionality, Safety of a Robotic Prosthesis for Transtibial Amputations

November 30, 2023 updated by: Claudio Macchi, Fondazione Don Carlo Gnocchi Onlus

Interventional Pilot Study on the Evaluation of Functionality, Degree of Safety and Reliability of a New Robotic Prosthesis for Treatment of Transtibial Lower Limb Amputations

The goal of this multicenter interventional pilot is to verify the functionality of a prosthesis for trans-tibial amputees.

The main question it aims to answer are:

  • Is to verify the technical functionality, safety and reliability of the propulsive lower limb prosthesis prototype, with active ankle, so as to provide indications regarding the technical and functional developments to be implemented in the finalization of the device.
  • Provide an indication of the functional effectiveness of the device and its satisfaction by patients.

Participants will perform:

  • walking tests inside parallel bars on flat and/or inclined terrain;
  • walking tests on treadmill;
  • stair climbing/descent tests.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

7

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • FI
      • Firenze, FI, Italy, 50143
        • IRCCS Fondazione Don Carlo Gnocchi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Trans-tibial lower limb amputation;
  • Medicare functional classification: Level K3-K4;
  • Subjects who have worn prostheses for at least 1 year (experienced wearers);
  • Use of prosthesis with energy-returning prosthetic foot.

Exclusion Criteria:

  • Relevant medical comorbidities (serious neurological pathologies, cardiovascular pathologies, diabetes/hypertension not stabilized, severe sensory deficits);
  • Wearers of implantable cardiac medical devices (PMK or AICD);
  • Cognitive impairment (MMSE corrected for age and education <24);
  • Inability or unavailability to provide informed consent;
  • Severe depressive and/or anxious symptoms.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Device Feasibility
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: prosthetic group
prosthetic group performs the entire protocol with the prosthesis prototype.
evaluation of functionality, degree of safety and reliability of the lower limb prosthesis prototype

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ad hoc check-list Adverse Event
Time Frame: baseline
questionnaire that evaluate the device feasability of the prosthesis and description of any adverse events.
baseline
ad hoc check-list Adverse Event
Time Frame: day 2
questionnaire that evaluate the device feasability of the prosthesis and description of any adverse events.
day 2
ad hoc check-list Adverse Event
Time Frame: day 3
questionnaire that evaluate the device feasability of the prosthesis and description of any adverse events.
day 3
ad hoc check-list Adverse Event
Time Frame: day 4
questionnaire that evaluate the device feasability of the prosthesis and description of any adverse events.
day 4
ad hoc check-list Adverse Event
Time Frame: day 5
questionnaire that evaluate the device feasability of the prosthesis and description of any adverse events.
day 5

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CR-10 Borg Scale
Time Frame: day 5
0-10 numerical rating scale that evaluate of the subjective perception of effort during walking
day 5
System usability scale
Time Frame: baseline
a questionnaire made up of 10 questions whose answers are yes structured on a Likert scale with values 0-100 that assess the usability of the prosthesis
baseline
System usability scale
Time Frame: day 5
a questionnaire made up of 10 questions whose answers are yes structured on a Likert scale with values 0-100 that assess the usability of the prosthesis
day 5
10mwt - 10 meters walking test
Time Frame: day 2
to assess the walking speed
day 2
10mwt - 10 meters walking test
Time Frame: day 3
to assess the walking speed
day 3
SCT - stair climb test
Time Frame: day 2
to assess the capability of climb 8 stairs
day 2
SCT - stair climb test
Time Frame: day 3
to assess the capability of climb 8 stairs
day 3
TUG - Timed Up and GO
Time Frame: day 2
to assess lower limb capability
day 2
TUG - Timed Up and GO
Time Frame: day 3
to assess lower limb capability
day 3
6mwt - 6 minute walking test on the treadmill
Time Frame: day 4
to assess the fatigue
day 4
6mwt - 6 minute walking test on the treadmill
Time Frame: day 5
to assess the fatigue
day 5
Gait analisys
Time Frame: day 5
to assess the gait pattern
day 5

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 21, 2020

Primary Completion (Actual)

November 10, 2022

Study Completion (Actual)

December 22, 2022

Study Registration Dates

First Submitted

November 8, 2023

First Submitted That Met QC Criteria

November 30, 2023

First Posted (Actual)

December 8, 2023

Study Record Updates

Last Update Posted (Actual)

December 8, 2023

Last Update Submitted That Met QC Criteria

November 30, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MOTU TT - studio clinico

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Amputation

Clinical Trials on WRL TTP

3
Subscribe